| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |